Imagin Medical Inc
Imagin Medical Inc., a urologic oncology company, focuses on the research, development, and commercialization of medical devices in the bio-chemistry industry. It has a license agreement with Lawrence Livermore National Security, LLC to develop, manufacture, and sell a medical imaging device. The company is headquartered in Vancouver, Canada.
Market Cap & Net Worth: Imagin Medical Inc (IMEXF)
Imagin Medical Inc (PINK:IMEXF) has a market capitalization of $1.08K ($1.08K) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #48125 globally and #14811 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Imagin Medical Inc's stock price $0.00 by its total outstanding shares 10830116 (10.83 Million).
Imagin Medical Inc Market Cap History: 2016 to 2025
Imagin Medical Inc's market capitalization history from 2016 to 2025. Data shows change from $595.66K to $1.08K (-56.00% CAGR).
Imagin Medical Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Imagin Medical Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of IMEXF by Market Capitalization
Companies near Imagin Medical Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Imagin Medical Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Imagin Medical Inc Historical Marketcap From 2016 to 2025
Between 2016 and today, Imagin Medical Inc's market cap moved from $595.66K to $ 1.08K, with a yearly change of -56.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $1.08K | -99.33% |
| 2024 | $162.45K | -58.33% |
| 2023 | $389.88K | -81.63% |
| 2022 | $2.12 Million | -45.40% |
| 2021 | $3.89 Million | +16.94% |
| 2020 | $3.32 Million | +716.49% |
| 2019 | $407.21K | -47.04% |
| 2018 | $768.94K | -62.03% |
| 2017 | $2.03 Million | +240.00% |
| 2016 | $595.66K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Imagin Medical Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.08K USD |
| MoneyControl | $1.08K USD |
| MarketWatch | $1.08K USD |
| marketcap.company | $1.08K USD |
| Reuters | $1.08K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.